Clinical Trials

Oncology Research - Clinical Trials

The J. Phillip Citta Cancer Center provides patients access to national and regional clinical research studies. The availability of these studies in the treatment of cancer, chemoprevention, and supportive care allow patients the option to participate in the latest treatment options including investigational drugs.

For more information, please call

Jonathan A. Gapilango RN MSN OCN
Director, Oncology Research & Oncology Data Ctr
J. Phillip Citta Regional Cancer Center
Community Medical Center

(732) 557-8239 office
(732) 557-8599 fax

Open Protocol List as of October 18, 2017

Breast Clinical Trials

A011104 / 6694
Effect of Preoperative Breast MRI on Surgical Outcomes, Costs and Quality of Life of Women with Breast Cancer

CK-SAPBI
A Multi-Institutional Registry for CyberKnife Stereotactic Accelerated Partial Breast Irradiation

NRG BR003
A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel with or without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer

Lung Clinical Trials

Lung Cancer Screening Registry
The ACR Lung Screening Registry (LCSR) is designed to systematically audit the quality of interpretation of screening lung CT exams

RTOG 1306
A Randomized Phase II study of Individualized Combined Modality Therapy for Stage III Non-Small Cell Lung Cancer (NSCLC)

A151216
Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)

A081105
A Randomized Double Blind Placebo Controlled Study of Erlotinib or Placebo in Patients with Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC)

E4512
A Phase III Trial for Surgically Resected Early Stage Non-Small Cell Lung Cancer: Crizotinib versus Placebo for patients with tumors harboring the ALK fusion protein

EA5142
Adjuvant Nivolumab in Resected Lung Cancers (ANVIL)
A Randomized Phase III Study of Nivolumab after Surgical Resection and Adjuvant Chemotherapy in Non-Small Cell Lung Cancers

TR(ACE) AssayClinical Specimen Study
Evaluation of the TR(ACE)® Assay for the Ability to Aid in Monitoring Disease Progress, Response to Therapy or for the Recurrent or Residual Disease for Patients with Previously Diagnosed Cancers (Stage III and IV Lung and Stage IV Breast

Colon Clinical Trial

NSABP Protocol C-13
A Phase III Randomized Placebo-Controlled Study Evaluating Regorafenib following completion of standard Chemotherapy for Patients with Stage III colon cancer (ARGO)

Cyberknife Clinical Trials

PCK-01 SBRT+ PD1 Sensitization
A Prospective Trial of Immunotherapy and Stereotactic Body Radiotherapy (SBRT) for the Treatment of Metastatic Lung Cancer: SBRT Sensitization of the Programmed Death-1 (PD-1) Effect

RSSSearch Patient Registry Protocol
An international, multi-center ongoing database designed to standardize the collection of data on the use of stereotactic surgery (SRS)/ stereotactic body radiation therapy (SBRT) systems in everyday practice

CK-SAPBI
A Multi-Institutional Registry for CyberKnife Stereotactic Accelerated Partial Breast Irradiation

UPMC #09-031
Prospective Evaluation of Hypofractionated Stereotactic Body Radiotherapy for Low and Intermediate Risk Prostate Cancer

NJCK 12-01
Prospective Evaluation of Hypofractionated Stereotactic Body Radiotherapy for High Risk Prostate Cancer

UPCI 10-027
Phase II Study For Curative Intent Treatment got Patients with Oligometastatic disease at Initial Presentation

UPCI # 10-028
Phase II Study of Stereotactic Radiosurgery / Stereotactic Body Radiation Therapy for Patients with Oligo-Recurrent Disease

NRG BR001
A Phase 1 Study of Stereotactic Body Radiotherapy (SBRT) for the Treatment of Multiple Metastases

NRG BR002
A Phase IIR/III Trial of Standard of Care Therapy with or without Stereotactic Body Radiotherapy (SBRT) and/or Surgical Ablation for Newly Oligometastatic Breast Cancer

[ top ]